Aurinia Pharmaceuticals AUPH Total debt
Total debt at other companies
Other financials
Where this comes from
Calculated from Aurinia Pharmaceuticals’s reported figures.
Plus components not separately reported this period.
The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aurinia Pharmaceuticals's total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aurinia Pharmaceuticals's total debt?
- Aurinia Pharmaceuticals (AUPH) reported total debt of $85.16M in Q1 2026.
- How has Aurinia Pharmaceuticals's total debt changed year-over-year?
- Aurinia Pharmaceuticals's total debt decreased by 7.9% year-over-year, from $92.42M to $85.16M.
- What is the long-term trend for Aurinia Pharmaceuticals's total debt?
- Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's total debt has grown at a 61.1% compound annual growth rate (CAGR), from $8.41M to $91.34M.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.